Mannitolin ja hypertonisen keittosuolan vaikutus hemodynamiikkaan, happoemästasapainoon ja veren hyytymi-seen tavoiteohjatun nestehoidon aikana subaraknoidaalivuotopotilailla.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-015784-13-FI

Enrollment

Registered

2011-02-10

Start date

2011-02-18

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkittavilla henkilöillä on leikkausta vaativa aneurysmaattinen subaraknoidaalivuoto. MedDRA version: 12.1 Level: LLT Classification code 10042316 Term: Subarachnoid haemorrhage

Interventions

Trade Name: Mannitol Baxter Viaflo 150 mg/ml Pharmaceutical Form: Solution for infusion INN or Proposed INN: mannitoli CAS Number: 69-65-8 Other descriptive name: MANNITOL Trade Name: Natriumklorid b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026